Homepage
Group
Manufacturing
BratskChemSyntez

BratskChemSyntez

Manufacturing active pharmaceutical ingredients for medicines used to treat diseases of major public health importance: tuberculosis, HIV infection, hepatitis and cancer

10
team members with a Candidate of Sciences degree
2013
company established in Bratsk
2,500 m²
research centre floor area

Management

Strategic management of the company

Ivan Sergeevich Dratsky

General Director

Today, building our own industrial base covering the full production cycle is particularly important to ensure reliable supplies and the continued development of Russia’s pharmaceutical industry.

BratskChemSyntez

Therapeutic expertise

Providing access to advanced medicines in key therapeutic areas

company portfolio

5
production lines
380
tonnes per year — planned production capacity
25 decares
floor area of manufacturing and ancillary premises

Manufacturing capabilities

Manufacturing APIs for medicines

001
Five specialised production areas
Equipment includes automatic nutsche filter dryers, isolators and reactors with capacities of up to 5,000 L.

Nine new lines are being commissioned, including an LYO-40 freeze dryer and automated antibiotic production areas.
002
Integrated production cycle
Two quality control laboratories, a microbiology laboratory and an in-house R&D centre. More than 40 analytical instruments are used for research and the creation of new medicines.
003
Product specialisation
Anti-tuberculosis APIs and general-purpose pharmaceutical ingredients

Manufacturing infrastructure